The Provoke™ PCL/CI Step Thru knee brace incorporates all the innovative features of the original Provoke™ brace, however is tailored more specifically for for combined ligament deficiencies that includes PCL injuries, by incorporating a posterior frame tibial cuff. Expertly crafted to meet individual patient needs, it offers superior support and mobility.
Utilizing high-grade Polyamide 2200 material from the aerospace industry and advanced design software, the Provoke™ PCL/CI features a sleek, low-profile frame and a hinge that mirrors the knee’s natural motion. As the lightest rigid knee brace available, it provides exceptional support, setting a new standard for PCL injury treatment.
The Provoke™ PCL/CI Step Thru ligament knee brace is digitally modelized and personalized for each leg shape using OssKin’s proprietary software. This allows for an ultra-precise fit to any morphology and total surface contact for extra comfort and control. Once modelized to an individual leg, the brace parts are 3D printed in state-of the art machines used in the aerospace and medical industry.
The Provoke™ PCL/CI knee brace is custom-designed and 3D-printed for each patient’s unique leg anatomy, providing unparalleled protection for combined ligaement and PCL injuries across all three anatomical planes of movement without any collateral effects. Featuring OssKin’s patented Asymmotion™ hinge system, the Provoke™ PCL/CI precisely tracks the knee’s natural tridimensional motion, ensuring maximum mobility and comfort. Experience the ultimate in personalized knee support with the Provoke™ PCL/CI, specifically engineered to address combined ligament and PCL deficiencies while maintaining full leg functionality.
The Provoke™ PCL/CI knee brace is more than a simple customizable knee brace. It is specifically personalized to cater to combined ligament and PCL tears, providing exceptional support and stability tailored to each individual’s unique needs.
Simply fill out this form, and we’ll help you find the nearest clinic to you.
OssKin © 2024